Date: Wednesday, May 28th, 2025
Time: 11:00AM-12:00PM (ET)
11:00 – 11:05 am
Introduction
* Sara Demy, Founder & CEO, Demy-Colton
* Steve Brozak, DMH, President & Co-Founder, WBB Securities
11:05 – 11:10 am
Understanding the Shortcomings of CAR-T Therapy
* Helen Heslop, MD, Professor, Department of Medicine & Pediatrics and Director, Center for Cell and Gene Therapy, Baylor College of Medicine
11:10 – 11:15 am
Overcoming the Current Limitations of CAR-T Therapy
* Malcolm Brenner, MD, PhD, Professor, Center for Cell & Gene Therapy and Founding Director, Center for Cell and Gene Therapy, Baylor College of Medicine
11:15 – 11:20 am
MAR-T Cells as a Novel Approach to Address Unmet Needs
* Juan Vera, MD, President & CEO, Marker Therapeutics
11:20 – 11:50 am
Roundtable Discussion
Moderator
* Richard Marfuggi, MD, DMH, WBB Research Institute
Panelists:
* Malcolm Brenner, MD, PhD, Professor, Center for Cell & Gene Therapy and Founding Director, Center for Cell and Gene Therapy, Baylor College of Medicine
* Helen Heslop, MD, Professor, Department of Medicine & Pediatrics and Director, Center for Cell and Gene Therapy, Baylor College of Medicine
* Manali Kamdar, MD, Associate Professor of Medicine and Clinical Director of Lymphoma Services, University of Colorado
* Geoffrey Shouse, DO, PhD, Hematologist-Oncologist & Researcher, City of Hope
* Juan Vera, MD, President & CEO, Marker Therapeutics
11:50 am – 12:00 pm
Q&A